As far as pharmaceutical mass torts go, the fen-phen litigation has been around for as long as any. But just because it’s mature litigation doesn’t mean that the old dog can’t do new tricks. Last month a fen-phen case produced the first post-
decision recognizing implied preemption, as we discussed
. This month we’ve got
Crowe v. Wyeth
”), 2009 WL 902351 (E.D. Pa. April 2, 2009), raising the
defense.
The what?
(more…)